wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40492253-2A5DC96A-F8A8-4D35-9D92-9F90369B6DAE
Q40492253-2A5DC96A-F8A8-4D35-9D92-9F90369B6DAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40492253-2A5DC96A-F8A8-4D35-9D92-9F90369B6DAE
Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose.
P2860
Q40492253-2A5DC96A-F8A8-4D35-9D92-9F90369B6DAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40492253-2A5DC96A-F8A8-4D35-9D92-9F90369B6DAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc0c7d856fc7d06061a3799753c17aac9fa5fad8
P2860
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.